RhyGaze

RhyGaze is a biotechnology company specializing in optogenetic gene therapy for vision restoration. The company develops novel gene therapies designed to restore vision in patients suffering from blindness by installing light sensitivity in retinal cells, specifically targeting cone cells. Based in Switzerland and the USA, RhyGaze aims to protect and restore the essential human sense of sight through cutting-edge genetic medicine.